Qualitest Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Qualitest Pharmaceuticals's estimated annual revenue is currently $61.3M per year.
- Qualitest Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Qualitest Pharmaceuticals has 305 Employees.
- Qualitest Pharmaceuticals grew their employee count by -3% last year.
Qualitest Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.1M | 85 | 8% | N/A | N/A |
#2 | $14.3M | 71 | 82% | N/A | N/A |
#3 | $44.8M | 223 | 7% | N/A | N/A |
#4 | $16.7M | 83 | 9% | N/A | N/A |
#5 | $25.7M | 128 | -4% | N/A | N/A |
#6 | $43.2M | 215 | 28% | N/A | N/A |
#7 | $1.3M | 13 | 117% | N/A | N/A |
#8 | $68.3M | 340 | 13% | N/A | N/A |
#9 | $13.7M | 68 | -1% | N/A | N/A |
#10 | $35.6M | 177 | -3% | N/A | N/A |
What Is Qualitest Pharmaceuticals?
Since 1983, the people of Qualitest have dedicated themselves to researching, manufacturing and delivering affordable, high-quality generic pharmaceuticals. Headquartered in Huntsville, Alabama, the company is now ranked in the industry top ten. With manufacturing facilities in Charlotte, North Carolina and Huntsville, Alabama the company has a portfolio exceeding 700 products.
keywords:N/AN/A
Total Funding
305
Number of Employees
$61.3M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Qualitest Pharmaceuticals News
... LGM Pharma, Lannett, Beijing 4A Biotech, Novartis Pharma Schweiz, North Star Rx, Par Pharmaceuticals, Qualitest Products, Teva Pharmaceuticals.
Labthink, UNION PARK CAPITAL, WEST PHARMACEUTICAL SERVICES INC., Qualitest International Inc., AMETEK Sensors, Test & Calibration (STC),...
Baclofen Market Size, Scope And Outlook | LGM Pharma, Lannett, Beijing 4A Biotech, Novartis Pharma Schweiz, North Star Rx, Par Pharmaceuticals, Qualitest...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $57.6M | 318 | 24% | N/A |
#2 | $57.8M | 319 | -4% | N/A |
#3 | $100.2M | 326 | -3% | N/A |
#4 | $112.4M | 333 | 10% | N/A |
#5 | $132.4M | 344 | 2% | N/A |